<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
------------------------------
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
March 29, 1999 0-21537
- ----------------------------------------------------- -------------------------
Date of Report (Date of earliest event reported) Commission File Number
PACIFIC BIOMETRICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 93-1211114
- -------------------------------- ---------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification Number)
incorporation or organization)
25621 Atlantic Ocean Drive, Suite A1
Lake Forest, CA 92630
----------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(949) 455-9724
----------------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE>
Item 5. Other Events.
On March 29, 1999, Pacific Biometrics, Inc. (the "Company") announced by press
release that it had received notification that the Nasdaq Listings
Qualifications Panel has delisted the Company's securities from the Nasdaq Stock
Market effective as of the close of business on March 29, 1999. This includes
the common stock, symbol PBMI, and the publicly traded warrants, symbol PBMIW.
This delisting decision will have an adverse impact on the liquidity of the
Company's securities, which may now trade on the OTC Bulletin Board or the
over-the-counter market. This may make it more difficult to trade in the
Company's securities or liquidate an investor's holdings. Also such delisting
may make it more difficult for the Company to raise additional capital.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) not applicable
(b) not applicable
(c) Exhibits
99 Press Release dated March 29, 1999
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: April 9, 1999 PACIFIC BIOMETRICS, INC.
By: /s/ Paul G. Kanan
----------------------------
Name: Paul G. Kanan
Title: President and Chief Executive Officer
3
<PAGE>
EXHIBIT 99
Press Release
For Release Immediately
Contact: Peter Ludlum
Pacific Biometrics, Inc.
949-455-9724
www.pacbio.com
PACIFIC BIOMETRICS ANNOUNCES NASDAQ DELISTING
LAKE FOREST, CA (March 29, 1999) .......... Pacific Biometrics, Inc. (Nasdaq:
PBMI), announced that the Company has been advised today that the Nasdaq
Listings Qualifications Panel has determined to delist the Company's securities
from the Nasdaq Stock Market effective with the close of business today, March
29, 1999. This includes the common stock, symbol PBMI, and the publicly traded
warrants, symbol PBMIW.
This delisting decision will have an adverse impact on the liquidity of the
Company's securities, which may now trade on the OTC Bulletin Board of the
over-the-counter market. This may make it more difficult to trade in the
Company's securities or liquidate an investor's holdings. Also such delisting
may make it more difficult for the Company to raise additional capital.
Pacific Biometrics, Inc. is an early stage company engaged in non-invasive
diagnostics and laboratory services to improve the detection and management of
chronic diseases. The Company is developing applications in diabetes and
osteoporosis based on two proprietary technology platforms, the
SalivaSac(Registered) collection device and the SweatPatch(Trademark).
4
